Alpha Teknova (TKNO) Net Equity Issued and Repurchased (2023 - 2024)
Alpha Teknova (TKNO) posted quarterly Net Equity Issued and Repurchased of $15.1 million for Q3 2024, down 33.93% year-over-year from $22.9 million in Q4 2023, and up 41021.62% quarter-over-quarter from -$37000.0 in Q1 2024.
Alpha Teknova (TKNO) Net Equity Issued and Repurchased (2023 - 2024) Analysis & Trends
Alpha Teknova (TKNO) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $15.1 million the latest figure, recorded in Q3 2024.
- In Q3 2024, Net Equity Issued and Repurchased fell 33.93% year-over-year to $15.1 million; the TTM figure through Dec 2025 stood at $15.1 million (changed 0.24% YoY), while the FY2024 annual figure was $15.1 million, down 32.88% from the prior year.
- Net Equity Issued and Repurchased rose to $15.1 million in Q3 2024 per TKNO's latest filing, from -$37000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $22.9 million in Q3 2023 and bottomed at -$412000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alpha Teknova | 396.90 Mn | 379.46 Mn | 4.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 15.14 Mn |
| Sep 30, 2024 | 15.14 Mn |
| Mar 31, 2024 | -37,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Dec 31, 2023 | -412,000.00 |
| Dec 31, 2023 | -412,000.00 |
| Sep 30, 2023 | 22.92 Mn |
| Sep 30, 2023 | 22.92 Mn |